City

Condition

End Stage Renal Disease (1)

Hemodialysis Vascular Access Failure (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

early phase 1 (1)

Sponsor

Mayo Clinic (1)

Collaborator

Intervention

1.25mg bevacizumab (1)

2.50mg bevacizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

hemodialysis vascular access failure

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

End Stage Renal Disease, Hemodialysis Vascular Access Failure Trial (1.25mg bevacizumab, 2.50mg bevacizumab)

Withdrawn

End Stage Renal Disease
Hemodialysis Vascular Access Failure

1.25mg bevacizumab
2.50mg bevacizumab

(no location specified)

Jul 6, 2020